Clinical Trial Update: Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial [Phase 4]

View source ↗

Summary

This clinical trial update notes a Phase 4 N-of-1 study evaluating lemborexant for insomnia in a patient with dementia, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia
• Frontotemporal Dementia
• Insomnia

Drugs mentioned

• Lemborexant (lemborexant)

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Insomnia, Dementia | Phase 4 | Status: RECRUITING